141 related articles for article (PubMed ID: 31756334)
1. Inhibitory effect of α
Liu QM; Xiao Q; Zhu X; Chen KF; Liu XW; Jiang RC; Wu D; Shi JM; Dai LJ; Huang JJ
Eur J Pharmacol; 2020 Mar; 870():172817. PubMed ID: 31756334
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen/androgen induced rat benign prostatic hyperplasia model in vivo.
Huang JJ; Cai Y; Yi YZ; Huang MY; Zhu L; He F; Liu XW; Huang BY; Yuan M
Eur J Pharmacol; 2016 Nov; 791():473-481. PubMed ID: 27615445
[TBL] [Abstract][Full Text] [Related]
3. Piperazine-Derived α
Xiao Q; Liu QM; Jiang RC; Chen KF; Zhu X; Ma L; Li WX; He F; Huang JJ
Front Pharmacol; 2020; 11():594038. PubMed ID: 33584271
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth.
Chagas-Silva F; Nascimento-Viana JB; Romeiro LA; Barberato LC; Noël F; Silva CL
Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):225-34. PubMed ID: 24213881
[TBL] [Abstract][Full Text] [Related]
6. Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.
Shimizu S; Shimizu T; Tsounapi P; Higashi Y; Martin DT; Nakamura K; Honda M; Inoue K; Saito M
PLoS One; 2015; 10(8):e0133798. PubMed ID: 26308715
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study).
Matsukawa Y; Funahashi Y; Takai S; Majima T; Ogawa T; Narita H; Kato M; Gotoh M
J Urol; 2017 Feb; 197(2):452-458. PubMed ID: 27615436
[TBL] [Abstract][Full Text] [Related]
8. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
[TBL] [Abstract][Full Text] [Related]
9. Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on α
Huang JJ; Zhang ZH; He F; Liu XW; Xu XJ; Dai LJ; Liu QM; Yuan M
Bioorg Med Chem Lett; 2018 Feb; 28(4):547-551. PubMed ID: 29422390
[TBL] [Abstract][Full Text] [Related]
10. Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.
Huang J; He F; Huang M; Liu X; Xiong Y; Huang Y; Zhu L; Yang Y; Xu X; Yuan M
Eur J Med Chem; 2015; 96():83-91. PubMed ID: 25874333
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α
Canale V; Rak A; Kotańska M; Knutelska J; Siwek A; Bednarski M; Nowiński L; Zygmunt M; Koczurkiewicz P; Pękala E; Sapa J; Zajdel P
Molecules; 2018 Aug; 23(9):. PubMed ID: 30158432
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.
Xu F; Chen H; Xu J; Liang X; He X; Shao B; Sun X; Li B; Deng X; Yuan M
Bioorg Med Chem; 2015 Dec; 23(24):7735-42. PubMed ID: 26643219
[TBL] [Abstract][Full Text] [Related]
13. New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.
Nascimento-Viana JB; Carvalho AR; Nasciutti LE; Alcántara-Hernández R; Chagas-Silva F; Souza PA; Romeiro LA; García-Sáinz JA; Noël F; Silva CL
J Pharmacol Exp Ther; 2016 Jan; 356(1):212-22. PubMed ID: 26493747
[TBL] [Abstract][Full Text] [Related]
14. Indolylpiperidine derivatives as potent and selective α1B adrenoceptor antagonists.
Hayashi R; Ohmori E; Moriwaki M; Kumagai H; Isogaya M
Bioorg Med Chem Lett; 2015 Sep; 25(18):3921-3. PubMed ID: 26238322
[TBL] [Abstract][Full Text] [Related]
15. Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.
Kojima Y; Sasaki S; Shinoura H; Hayase M; Kubota Y; Hayashi Y; Tsujimoto G; Kohri K
Prostate; 2007 Sep; 67(12):1285-92. PubMed ID: 17626248
[TBL] [Abstract][Full Text] [Related]
16. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
[TBL] [Abstract][Full Text] [Related]
17. The α1-adrenoceptor-mediated human hyperplastic prostate cells proliferation is impaired by EGF receptor inhibition.
Nascimento-Viana JB; Alcántara-Hernández R; Oliveira-Barros E; Castello Branco LA; Feijó PR; Soares Romeiro LA; Nasciutti LE; Noël F; García-Sáinz JA; Silva CLM
Life Sci; 2019 Dec; 239():117048. PubMed ID: 31730867
[TBL] [Abstract][Full Text] [Related]
18. A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.
Tatemichi S; Akiyama K; Kobayashi M; Yamazaki Y; Yokoyama O; Uruno T
J Urol; 2006 Sep; 176(3):1236-41. PubMed ID: 16890732
[TBL] [Abstract][Full Text] [Related]
19. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J
J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological properties of naftopidil, a drug for treatment of the bladder outlet obstruction for patients with benign prostatic hyperplasia].
Ikegaki I
Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):63-9. PubMed ID: 10976457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
